Clinical Research
How to Use Pharmacogenomic Information to Reduce the Risk of Experiencing Adverse Events
Pharmacogenomics is the study of the genes their structure function polymorphisms transcription and translation how they interact with each other and with environment
COVID-19
WHERE ARE WE HEADING IN 2022?
COVID has posed an unprecedented threat to the health and economy globally since its first detection in December with more than million cases and million deaths as of February
Dissemination of SARS-CoV-2 and the Pathogenesis of COVID-19
Something wicked this way comes
An inverse relationship between aerosolisation of mould spores and incidence of seasonal influenzalike illnesses ILI including COVID has been demonstrated in Chicago
Clinical Strategy for Successful Cell and Gene Therapies
How did I get here?
And now its happening How did we get here We got here because the science has moved forward So if you look at the products that we have approved most recently the science is exquisite And if you look at products that have such strong science behind them
THE FUTURE OF RESEARCH
Importance of accelerated clinical trials for evidence-based treatments
Over the past year the COVID pandemic has heightened the urgency for clinical research to understand the disease uncover treatment plans and develop vaccines to treat a disease that was once unknown to the world It was equally crucial that findings were swiftly made available to the public to prevent misleading information from undermining the publ...
Nanotechnology to Combat Covid-19
Rapid viral outbreaks have caused great inconvenience to mankind especially since the last decade The latest addition to the list is severe acute respiratoryrelated coronavirus SARSCoV or more commonly COVID Figure As of September this virus has a spread over countries around the world affected people and caused deaths Nanotechnology and nan...
Crucial Decision-making in Drug Development for COVID-19
Modelling and simulation guides
Modelling and simulation has been growing rapidly in impact and is now actively used by biopharmaceutical companies worldwide for drug development and regulatory agencies for review and approval
Treating COVID-19
Global pharma makes early strides
The COVID pandemic hit industries across the globe as countries adopted various measures that included travel restrictions border closures to imposing nationwide lockdown in a bid to contain or slowdown the spread of virus Almost six months after the novel corona virus was first diagnosed in China the number of patients currently standing at milli...
COVID-19 PANDEMIC
RISK ASSESSMENT AND FUTURE CONTROL
There is a widespread panic around the world about COVID caused by the novel Coronavirus In late December China health Officials reported an outbreak of pneumonia of unknown origin in Wuhan Hubei province The World Health Organisation WHO originally called this disease Novel Coronavirusinfected Pneumonia NCIP and this novel coronavirus was provisi...
COVID-19
FROM A CHALLENGE TO AN OPPORTUNITY FOR INDIAN PHARMA TO BECOME SELF-RELIANT
China and India are the leading players in bulk drugs and manufacture more than per cent of global bulk drug China is the largest bulk drug supplier in world and India is second As reported by ministry of commerce India exported drugs formulation and biologicals of billion USD in which increased to billion USD in increase
